pharma · Breast Neoplasms · Radiation Injuries
Sun Yat-sen Memorial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen Memorial trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Guangzhou, CN HQ
32 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Employees
- 32
- Programs
- 7
- Drugs
- 16
- Patents
- 0
Sun Yat-sen Memorial clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to Sun Yat-sen Memorial programs — each row shows trial ID, program name, phase, status, and indication.
Sun Yat-sen Memorial trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Sun Yat-sen Memorial.
-
Trastuzumab and neratinib — Phase 3
Clinical update -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab — Unknown
Clinical update -
Fulvestrant combined with Pyrotinib — Phase 3
Clinical update -
Donepezil Hydrochloride — Phase 2
Clinical update -
Carrellizumab + Capecitabine — Phase 3
Clinical update -
Niraparib — Phase 2
Clinical update -
Pregabalin — Phase 2
Clinical update